跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 77,746 条关于
“PD-1 x VEGF bifunctional antibody”
全部
77,746
临床试验
47,449
药物
9,988
机构
1,493
资讯
18,816
去年
NAYA Biosciences Expands Oncology Pipeline with Novel PD-1 x VEGF Antibody
10个月前
Crescent Biopharma Advances PD-1 x VEGF Bispecific Antibody CR-001 Toward Phase 1 Trial
去年
BioNTech's VEGF x PD-L1 Bispecific BNT327 Shows Promise in TNBC
2年前
Akeso's Bispecific Antibodies Show Promise in Lung and Colorectal Cancers
8个月前
AbbVie Secures $5.6 Billion Licensing Deal for Novel PD-1/VEGF Bispecific Antibody RC148
去年
Merck Expands Oncology Pipeline with $3.2B Deal for LaNova's Bispecific Antibody
11个月前
CStone Pharmaceuticals Presents First-in-Class PD-1/VEGF/CTLA-4 Trispecific Antibody Data at ESMO 2025
7个月前
Alphamab Advances First PD-L1 x VEGFR2 Antibody-Drug Conjugate JSKN027 Into Clinical Trials
前天
FDA Grants Fast Track Designation to OncoC4's PD-1/VEGF Bispecific Cesalatamig for PD-(L)1-Refractory NSCLC
去年
OncoC4 Advances PD-1/VEGF Bispecific Antibody AI-081 to Phase 2 Trial Following Promising Early Efficacy Data
第 1 页，共 1882 页
上一页
下一页
